| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHPSYC.1995.03950220015005 |
| P698 | PubMed publication ID | 7575100 |
| P50 | author | Patricia S. Goldman-Rakic | Q510587 |
| P2093 | author name string | Rajkowska G | |
| Selemon LD | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 805-18; discussion 819-20 | |
| P577 | publication date | 1995-10-01 | |
| P1433 | published in | JAMA Psychiatry | Q635830 |
| P1476 | title | Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. | |
| P478 | volume | 52 |
| Q35532688 | A broad cortical reserve accelerates response to cognitive enhancement therapy in early course schizophrenia |
| Q30465716 | A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia |
| Q41454750 | A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunction |
| Q48438450 | A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives |
| Q24657354 | A review of MRI findings in schizophrenia |
| Q36070114 | A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia |
| Q48266293 | A transcranial magnetic stimulation study of abnormal cortical inhibition in schizophrenia. |
| Q41581748 | A two-process theory of schizophrenia: evidence from studies in post-mortem brain |
| Q48369379 | A.E. Bennett Research Award. Prenatal rubella, premorbid abnormalities, and adult schizophrenia |
| Q37384458 | Aberrant high-frequency desynchronization of cerebellar cortices in early-onset psychosis. |
| Q48607704 | Abnormalities of thalamic volume and shape detected in fetally irradiated rhesus monkeys with high dimensional brain mapping. |
| Q44061504 | Alterations in MAP2 immunocytochemistry in areas 9 and 32 of schizophrenic prefrontal cortex |
| Q38954270 | Alterations in Prefrontal Cortical Circuitry and Cognitive Dysfunction in Schizophrenia. |
| Q33922855 | Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder |
| Q30979852 | Alterations of the occipital lobe in schizophrenia |
| Q33725848 | Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia |
| Q36525031 | Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene |
| Q37663262 | Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia |
| Q30480191 | Altered volume and hemispheric asymmetry of the superficial cortical layers in the schizophrenia planum temporale |
| Q48435520 | Amphetamine sensitization alters dendritic morphology in prefrontal cortical pyramidal neurons in the non-human primate |
| Q37424567 | An MRI-based approach for the measurement of the dorsolateral prefrontal cortex in humans |
| Q35810076 | Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia |
| Q48345004 | Anomalies of cerebral asymmetry in schizophrenia interact with gender and age of onset: a post-mortem study |
| Q39319258 | Antibodies directed to Neisseria gonorrhoeae impair nerve growth factor-dependent neurite outgrowth in Rat PC12 cells |
| Q39020161 | Antibodies directed to the gram-negative bacterium Neisseria gonorrhoeae cross-react with the 60 kDa heat shock protein and lead to impaired neurite outgrowth in NTera2/D1 cells. |
| Q38360887 | Antipsychotic drug treatment induces differential gene expression in the rat cortex. |
| Q31864319 | Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex |
| Q37104888 | Are patients with schizophrenia impaired in processing non-emotional features of human faces? |
| Q41181327 | Assessing neural tuning for object perception in schizophrenia and bipolar disorder with multivariate pattern analysis of fMRI data |
| Q26781630 | Associating schizophrenia, long non-coding RNAs and neurostructural dynamics |
| Q48459109 | Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer's disease |
| Q48300352 | Automated image analysis of disturbed cytoarchitecture in Brodmann area 10 in schizophrenia. |
| Q49131119 | Automated image analysis of disturbed cytoarchitecture in Brodmann area 10 in schizophrenia: a post-mortem study. |
| Q73553166 | Basal ganglia and cerebellar loops: motor and cognitive circuits |
| Q38787171 | Behavioral Resilience and Sensitivity to Locally Restricted Cortical Migration Deficits Induced by In Utero Knockdown of Disabled-1 in the Adult Rat. |
| Q33875986 | Behavioral abnormalities with disruption of brain structure in mice overexpressing VGF. |
| Q34413325 | Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia |
| Q60659100 | Brain development: the clinical perspective |
| Q48375454 | Brain functions and psychiatric disorders. A clinical view |
| Q36660287 | Brain gray matter phenotypes across the psychosis dimension |
| Q37058646 | Brain structure, cognition and negative symptoms in schizophrenia are associated with serum levels of polysialic acid-modified NCAM. |
| Q37411410 | Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study |
| Q37078047 | Brain-derived neurotropic factor/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia |
| Q48180655 | Calbindin immunoreactivity in the hippocampal formation and neocortex of schizophrenics |
| Q37323601 | Can structural MRI indices of cerebral integrity track cognitive trends in executive control function during normal maturation and adulthood? |
| Q48565571 | Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics |
| Q36792147 | Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illness |
| Q37827944 | Catecholamine modulation of prefrontal cortical cognitive function |
| Q34692741 | Cell pathology in bipolar disorder |
| Q40873917 | Cellular and molecular neuropathology of schizophrenia: new directions from developmental neurobiology. |
| Q36400712 | Changes in Astroglial Markers in a Maternal Immune Activation Model of Schizophrenia in Wistar Rats are Dependent on Sex. |
| Q46048346 | Changes in cortical thickness in the frontal lobes in schizophrenia are a result of thinning of pyramidal cell layers |
| Q33653196 | Chaos theories and therapeutic commonalities among depression, Parkinson's disease, and cardiac arrhythmias |
| Q36477107 | Classification matters for catatonia and autism in children |
| Q30476447 | Cognitive control deficits in schizophrenia: mechanisms and meaning |
| Q58164139 | Cognitive coordination and its neurobiological bases: A new continent to explore |
| Q33179619 | Cognitive dysfunction in schizophrenia: unifying basic research and clinical aspects |
| Q44419901 | Cognitive function in euthymic bipolar I disorder |
| Q38072452 | Cognitive interventions targeting brain plasticity in the prodromal and early phases of schizophrenia |
| Q58163973 | Computational Modeling of Contrast Sensitivity and Orientation Tuning in First-Episode and Chronic Schizophrenia |
| Q36265639 | Consequences of large interindividual variability for human brain atlases: converging macroscopical imaging and microscopical neuroanatomy |
| Q36282024 | Consistency and interpretation of changes in millimeter-scale cortical intrinsic curvature across three independent datasets in schizophrenia |
| Q37090335 | Contribution of coherent motion to the perception of biological motion among persons with Schizophrenia |
| Q36973262 | Contributions of low and high spatial frequency processing to impaired object recognition circuitry in schizophrenia |
| Q34642867 | Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation. |
| Q33288189 | Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls |
| Q34017293 | Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia |
| Q39388021 | Cortical Thickness of Functionally Defined Visual Areas in Schizophrenia and Bipolar Disorder |
| Q73081300 | Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia |
| Q45294154 | Cortical peptide changes in Huntington's disease may be independent of striatal degeneration |
| Q33638524 | Cortical surface characteristics among offspring of schizophrenia subjects |
| Q35674895 | Cortical thickness and surface area in neonates at high risk for schizophrenia |
| Q48364671 | Course of psychopathology, cognition and neurobiological abnormality in schizophrenia: developmental origins and amelioration by antipsychotics? |
| Q48472359 | Craniofacial dysmorphogenesis in fetally irradiated nonhuman primates: implications for the neurodevelopmental hypothesis of schizophrenia |
| Q29547388 | Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models |
| Q48705712 | Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia |
| Q36756368 | Deciphering the disease process of schizophrenia: the contribution of cortical GABA neurons |
| Q33847022 | Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia |
| Q48397485 | Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology |
| Q37082847 | Decreased calcineurin immunoreactivity in the postmortem brain of a patient with schizophrenia who had been prescribed the calcineurin inhibitor, tacrolimus, for leukemia. |
| Q37126845 | Decreased neurotrophic response to birth hypoxia in the etiology of schizophrenia. |
| Q46967047 | Decreased numerical density of kainate receptor-positive neurons in the orbitofrontal cortex of chronic schizophrenics |
| Q48227957 | Decreased volume and increased asymmetry of the anterior limb of the internal capsule in patients with schizophrenia |
| Q48634483 | Deficits in gray matter volume are present in schizophrenia but not bipolar disorder |
| Q39285672 | Deficits in high- (>60 Hz) gamma-band oscillations during visual processing in schizophrenia |
| Q50923416 | Deficits in multiple systems of working memory in schizophrenia. |
| Q33179819 | Defining the course of brain structural change and plasticity in schizophrenia |
| Q60440780 | Delayed visual NA potential in remitted schizophrenia: a new vulnerability marker for psychotic relapse under low-dose medication |
| Q26991935 | Dendritic spine pathology in schizophrenia |
| Q50307306 | Depletion of MAP2 expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals. |
| Q35205003 | Depression: what we can learn from postmortem studies |
| Q45373153 | Detailed DARPP-32 expression profiles in postmortem brains from patients with schizophrenia: an immunohistochemical study |
| Q33946985 | Developing therapeutics for schizophrenia and other psychotic disorders |
| Q33813139 | Development, disease and degeneration in schizophrenia: a unitary pathophysiological model |
| Q43590751 | Developmental and stress-related changes of neurotrophic factor gene expression in an animal model of schizophrenia |
| Q33374181 | Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia |
| Q28305403 | Developmental insanity or dementia praecox: was the wrong concept adopted? |
| Q48683925 | Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex |
| Q42108290 | Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia |
| Q44189362 | Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration |
| Q35737237 | Direct and indirect effects of fetal irradiation on cortical gray and white matter volume in the macaque |
| Q60242723 | Disordered functional connectivity in schizophrenia1 |
| Q36576003 | Distinct abnormalities of the primate prefrontal cortex caused by ionizing radiation in early or midgestation |
| Q41518710 | Dopamine, the prefrontal cortex and schizophrenia |
| Q50540624 | Dorsal Forebrain-Specific Deficiency of Reelin-Dab1 Signal Causes Behavioral Abnormalities Related to Psychiatric Disorders. |
| Q33898360 | Dual cytoarchitectonic trends: an evolutionary model of frontal lobe functioning and its application to psychopathology |
| Q33303667 | Dysconnection topography in schizophrenia revealed with state-space analysis of EEG. |
| Q73528520 | Dysregulation of dopamine and pathology of prefrontal neurons: neuroimaging studies in schizophrenia and related animal models |
| Q34576434 | Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys |
| Q36850555 | Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia |
| Q33302991 | Elevated GRIA1 mRNA expression in Layer II/III and V pyramidal cells of the DLPFC in schizophrenia. |
| Q48487638 | Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain |
| Q48860398 | Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex |
| Q33692855 | Epilepsy, schizophrenia, and the extended amygdala |
| Q73553135 | Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia |
| Q33725843 | Evidence for altered trisynaptic circuitry in schizophrenic hippocampus |
| Q45291818 | Evidence for progression in frontal cortical pathology in late-stage Huntington's disease |
| Q30620561 | Evidence of fronto-thalamic involvement in schizophrenia |
| Q37480047 | Executive function, neural circuitry, and genetic mechanisms in schizophrenia |
| Q35054901 | Experience effects on brain development: possible contributions to psychopathology |
| Q36876003 | Familial and developmental abnormalities of front lobe function and neurochemistry in schizophrenia. |
| Q37315896 | First-episode schizophrenic psychosis differs from first-episode affective psychosis and controls in P300 amplitude over left temporal lobe. |
| Q48258798 | Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study |
| Q33679782 | Forebrain induction, retinoic acid, and vulnerability to schizophrenia: insights from molecular and genetic analysis in developing mice |
| Q94586001 | Frequency-dependent gating of feedforward inhibition in thalamofrontal synapses |
| Q44597810 | Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study |
| Q33514264 | Fronto-temporal dysfunction in schizophrenia: A selective review |
| Q28237319 | Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome |
| Q35916950 | GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia |
| Q35587241 | GABA and Schizophrenia: A Review of Basic Science and Clinical Studies |
| Q73553173 | GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia |
| Q34251137 | Gene expression analysis implicates a death receptor pathway in schizophrenia pathology |
| Q80594170 | Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients |
| Q35103424 | Genetically mediated brain abnormalities in schizophrenia |
| Q35047072 | Glia pathology in the prefrontal cortex in alcohol dependence with and without depressive symptoms |
| Q34384584 | Glial cell abnormalities in major psychiatric disorders: the evidence and implications |
| Q73154099 | Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder |
| Q34415862 | Global white matter abnormalities in schizophrenia: a multisite diffusion tensor imaging study |
| Q34199632 | Glucocorticoid receptor 1B and 1C mRNA transcript alterations in schizophrenia and bipolar disorder, and their possible regulation by GR gene variants. |
| Q34343734 | Glucocorticoid receptor mRNA and protein isoform alterations in the orbitofrontal cortex in schizophrenia and bipolar disorder |
| Q34424470 | Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla. |
| Q49019867 | Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain |
| Q48557473 | Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample |
| Q24649621 | Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia |
| Q30474409 | Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions |
| Q48227969 | Gyrification abnormalities in childhood- and adolescent-onset schizophrenia. |
| Q48498123 | Haloperidol induces persistent down-regulation of tyrosine hydroxylase immunoreactivity in substantia nigra but not ventral tegmental area in the rat. |
| Q30422323 | Hemispheric asymmetry of primary auditory cortex and Heschl's gyrus in schizophrenia and nonpsychiatric brains |
| Q34766555 | Hemispheric comparisons of neuron density in the planum temporale of schizophrenia and nonpsychiatric brains |
| Q38153036 | High-frequency neural oscillations and visual processing deficits in schizophrenia |
| Q38464009 | Hippocampal Pruning as a New Theory of Schizophrenia Etiopathogenesis |
| Q28293352 | Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia |
| Q34098184 | Histopathology of the prefrontal cortex in major depression: what does it tell us about dysfunctional monoaminergic circuits? |
| Q31054567 | History of the Concept of Disconnectivity in Schizophrenia |
| Q30655570 | Imaging normal and abnormal brain development: new perspectives for child psychiatry |
| Q36440915 | Imaging phenotypes and genotypes in schizophrenia |
| Q73274413 | Immunohistochemistry of neural markers for the study of the laminar architecture in celloidin sections from the human cerebral cortex |
| Q36597061 | Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia |
| Q40277970 | In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia |
| Q73524564 | Increased dendritic MAP2 expression in the hippocampus in schizophrenia |
| Q48153941 | Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure |
| Q44963323 | Influence of the hippocampus on interneurons of the rat prefrontal cortex |
| Q30532052 | Insights and treatment options for psychiatric disorders guided by functional MRI |
| Q34247716 | Interneuron dysfunction in psychiatric disorders |
| Q48102746 | Interstitial cells of the white matter in the inferior parietal cortex in schizophrenia: An unbiased cell-counting study |
| Q33988843 | Intrinsic excitatory connections in the prefrontal cortex and the pathophysiology of schizophrenia |
| Q35049206 | Intrinsic sensory deprivation induced by neonatal capsaicin treatment induces changes in rat brain and behaviour of possible relevance to schizophrenia |
| Q36262192 | Investigating the neurodevelopmental hypothesis of schizophrenia |
| Q37182549 | Ionotropic glutamate receptor mRNA expression in the human thalamus: absence of change in schizophrenia |
| Q36568049 | Is active psychosis neurotoxic? |
| Q37147332 | Is brain banking of psychiatric cases valuable for neurobiological research? |
| Q41376152 | Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? |
| Q34404767 | Lack of change in markers of presynaptic terminal abundance alongside subtle reductions in markers of presynaptic terminal plasticity in prefrontal cortex of schizophrenia patients |
| Q46581758 | Lack of effect of antipsychotics on BNDF and NGF levels in hippocampus of Wistar rats |
| Q48574693 | Layer V neurons bear the majority of mRNAs encoding the five distinct dopamine receptor subtypes in the primate prefrontal cortex |
| Q48488796 | Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia |
| Q38309861 | Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients |
| Q41367318 | Linking mind and brain in the study of mental illnesses: a project for a scientific psychopathology |
| Q37564007 | Linking white and grey matter in schizophrenia: oligodendrocyte and neuron pathology in the prefrontal cortex |
| Q48884106 | Local and distributed effects of apomorphine on fronto-temporal function in acute unmedicated schizophrenia |
| Q33814201 | Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. |
| Q36145602 | Longitudinal progression of frontal and temporal lobe changes in schizophrenia |
| Q38064198 | Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia |
| Q47820010 | Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia |
| Q57739276 | Low frontal electroencephalographic coherence in neuroleptic-free schizophrenic patients |
| Q57601601 | MEG resting-state oscillations and their relationship to clinical symptoms in schizophrenia |
| Q46177098 | MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients |
| Q33921880 | Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia |
| Q57262523 | Mapping Cortical Thickness and Gray Matter Concentration in First Episode Schizophrenia |
| Q33944802 | Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia |
| Q35069372 | Maternal infection and white matter toxicity |
| Q22241430 | Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia |
| Q36069511 | Medial-frontal cortex hypometabolism in chronic phencyclidine exposed rats assessed by high resolution magic angle spin 11.7 T proton magnetic resonance spectroscopy |
| Q35062996 | Membrane potential depolarization causes alterations in neuron arrangement and connectivity in cocultures |
| Q41432838 | Mesoprefrontal dopaminergic neurons: can tyrosine availability influence their functions? |
| Q37168678 | MicroRNA function is required for neurite outgrowth of mature neurons in the mouse postnatal cerebral cortex |
| Q47841028 | Modular-level alterations of structure-function coupling in schizophrenia connectome. |
| Q41409938 | Molecular biological investigations into the role of the NMDA receptor in the pathophysiology of schizophrenia. |
| Q28138248 | Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex |
| Q48208784 | Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression |
| Q34470801 | Morphometric methods for studying the prefrontal cortex in suicide victims and psychiatric patients |
| Q37296947 | Motor stereotypies and cognitive perseveration in non-human primates exposed to early gestational irradiation |
| Q58698014 | Multidimensional Connectomics and Treatment-Resistant Schizophrenia: Linking Phenotypic Circuits to Targeted Therapeutics |
| Q35599805 | Multimodal analyses identify linked functional and white matter abnormalities within the working memory network in schizophrenia |
| Q81407975 | Multimodal imaging in psychiatry: the electroencephalogram as a complement to other modalities |
| Q48498017 | Multiple regression analysis of relationship between frontal lobe phosphorus metabolism and clinical symptoms in patients with schizophrenia |
| Q42192369 | NMDA receptor and schizophrenia: a brief history |
| Q43238242 | NMDA receptors subserve persistent neuronal firing during working memory in dorsolateral prefrontal cortex |
| Q52168810 | Neural correlates of memory organization deficits in schizophrenia. A single photon emission computed tomography study with 99mTc-ethyl-cysteinate dimer during a verbal learning task. |
| Q35236271 | Neural models of schizophrenia |
| Q34399238 | Neural network models of schizophrenia |
| Q38310750 | Neural oscillations as a translational tool in schizophrenia research: rationale, paradigms and challenges |
| Q30698640 | Neuroanatomy and neurophysiology in schizophrenia |
| Q34384575 | Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity. |
| Q34675943 | Neurodevelopment, GABA system dysfunction, and schizophrenia |
| Q41743488 | Neurodevelopmental and neuroprogressive processes in schizophrenia. Antithetical or complementary, over a lifetime trajectory of disease? |
| Q34662630 | Neurogenic actions of atypical antipsychotic drugs and therapeutic implications |
| Q37981491 | Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments |
| Q34205693 | Neuron density and serotonin receptor binding in prefrontal cortex in suicide |
| Q46114621 | Neuron density is decreased in the prefrontal cortex in Williams syndrome |
| Q34775710 | Neuronal calcium-binding proteins and schizophrenia. |
| Q40901208 | Neuropathological studies of brain tissue in schizophrenia |
| Q37217991 | Neuropathology of Huntington's disease |
| Q33306132 | Neuropathology of schizophrenia: a mini review |
| Q37624654 | Neuroplasticity of excitatory and inhibitory cortical circuits in schizophrenia. |
| Q36931624 | Neuroplasticity of neocortical circuits in schizophrenia. |
| Q38209914 | Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries |
| Q36794279 | New genes associated with schizophrenia in neurite formation: a review of cell culture experiments |
| Q33580900 | No Association between Cortical Gyrification or Intrinsic Curvature and Attention-deficit/Hyperactivity Disorder in Adolescents and Young Adults |
| Q73711369 | No deficit in total number of neurons in the prefrontal cortex in schizophrenics |
| Q74292086 | Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia |
| Q50533007 | Occipital bending in schizophrenia. |
| Q36676567 | Occipital lobe gray matter volume in male patients with chronic schizophrenia: A quantitative MRI study |
| Q51943076 | Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. |
| Q34259921 | Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia |
| Q34494844 | Oxidative stress in schizophrenia: An integrated approach |
| Q41723380 | P300 reduction and prolongation with illness duration in schizophrenia |
| Q41540815 | Pathogenesis of Tourette's syndrome |
| Q48527923 | Patterns of regional cortical dysmorphology distinguishing schizophrenia and chronic alcoholism |
| Q33916365 | Perception of biological motion in schizophrenia and healthy individuals: a behavioral and FMRI study. |
| Q36952179 | Perinatal complications and schizophrenia: involvement of the immune system |
| Q60439965 | Phenomenology, context, and self-experience in schizophrenia |
| Q33367610 | Pieces of the schizophrenia puzzle fall into place |
| Q28077391 | Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review |
| Q35712176 | Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes |
| Q33924323 | Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells |
| Q39998926 | Potential application as screening and drug designing tools of cytoarchitectural deficiencies present in three animal models of schizophrenia |
| Q64113348 | Prefrontal Cortical and Behavioral Adaptations to Surgical Delivery Mediated by Metabolic Principles |
| Q33754429 | Prefrontal cortex, negative symptoms, and schizophrenia: an MRI study |
| Q37478385 | Prefrontal cortical thickness in first-episode psychosis: a magnetic resonance imaging study |
| Q36054203 | Prefrontal deviations in function but not volume are putative endophenotypes for schizophrenia |
| Q38395725 | Prefrontal dysfunction and a monkey model of schizophrenia |
| Q33902022 | Prenatal disruption of neocortical development alters prefrontal cortical neuron responses to dopamine in adult rats |
| Q47673850 | Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development |
| Q36508050 | Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia |
| Q48308507 | Primary visual cortex volume and total neuron number are reduced in schizophrenia |
| Q34090316 | Primate models of schizophrenia: future possibilities |
| Q38548675 | Processing of auditory stimuli during visual attention in patients with schizophrenia. |
| Q37463751 | Processing speed is correlated with cerebral health markers in the frontal lobes as quantified by neuroimaging |
| Q36395044 | Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia |
| Q37162646 | Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals |
| Q48338688 | Progressive neurodegeneration after intracerebroventricular kainic acid administration in rats: implications for schizophrenia? |
| Q34081577 | Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients |
| Q26766821 | Proteomics Research in Schizophrenia |
| Q46470298 | Proton MRS in twin pairs discordant for schizophrenia |
| Q46840294 | Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia |
| Q44112647 | Proton magnetic resonance spectroscopy of the inferior frontal gyrus and thalamus and its relationship to verbal learning task performance in patients with schizophrenia: a preliminary report |
| Q57300096 | Putative Astroglial Dysfunction in Schizophrenia: A Meta-Analysis of H-MRS Studies of Medial Prefrontal Myo-Inositol |
| Q48559941 | Quantitative analysis of cell columns in the cerebral cortex |
| Q48802137 | Quantitative magnetic resonance imaging of the corpus callosum in childhood onset schizophrenia |
| Q48707366 | Radiation-induced, lamina-specific deletion of neurons in the primate visual cortex |
| Q36024027 | Rapid seasonal-like regression of the adult avian song control system. |
| Q36686912 | Rat modeling for GABA defects in schizophrenia |
| Q44507092 | Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia |
| Q48486539 | Reduced corticocortical connectivity can induce speech perception pathology and hallucinated 'voices'. |
| Q32000373 | Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia |
| Q34064021 | Reduced glial and neuronal packing density in the orbitofrontal cortex in alcohol dependence and its relationship with suicide and duration of alcohol dependence |
| Q56094601 | Reduced interneuronal space in schizophrenia |
| Q34295745 | Reduced myelin basic protein and actin-related gene expression in visual cortex in schizophrenia |
| Q42029797 | Reduced visual surround suppression in schizophrenia shown by measuring contrast detection thresholds |
| Q43593933 | Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder |
| Q37374497 | Reductions in neuronal density in elderly depressed are region specific |
| Q46531764 | Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia |
| Q33813149 | Regional brain volume change over the life-time course of schizophrenia |
| Q34126954 | Regional prefrontal cortex gray matter volumes in youth at familial risk for schizophrenia from the Harvard Adolescent High Risk Study |
| Q48459917 | Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders |
| Q51994574 | Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. |
| Q48277950 | Relationship among neuroimaging indices of cerebral health during normal aging |
| Q35847706 | Relationship between dose, drug levels, and D2 receptor occupancy for the atypical antipsychotics risperidone and paliperidone |
| Q48492733 | Relationship between exploratory eye movements and brain morphology in schizophrenia spectrum patients: voxel-based morphometry of three-dimensional magnetic resonance imaging |
| Q36848277 | Relationship between somatostatin and death receptor expression in the orbital frontal cortex in schizophrenia: a postmortem brain mRNA study |
| Q45221811 | Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. |
| Q33429548 | Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders |
| Q33187904 | Response-monitoring dysfunction in aging and Alzheimer's disease: an event-related potential study |
| Q34356672 | Resting neural activity distinguishes subgroups of schizophrenia patients |
| Q73874580 | Schizophrenia |
| Q33306645 | Schizophrenia and sex associated differences in the expression of neuronal and oligodendrocyte-specific genes in individual thalamic nuclei |
| Q48675721 | Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons |
| Q41755616 | Schizophrenia as a developmental disorder of the cerebral cortex |
| Q36900178 | Schizophrenia seen as a deficit in the modulation of cortical minicolumns by monoaminergic systems |
| Q35093256 | Schizophrenia, neurodevelopment and corpus callosum |
| Q52201813 | Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach. |
| Q48800734 | Schizophrenia. An emerging pathophysiology |
| Q47677836 | Schizophrenia: Basic and Clinical |
| Q37792088 | Schizophrenia: Treatment Targets Beyond Monoamine Systems |
| Q26797157 | Schizophrenia: a tale of two critical periods for prefrontal cortical development |
| Q51192435 | Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. |
| Q44208824 | Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia |
| Q36756374 | Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug development |
| Q47240878 | Shape and size of the corpus callosum in schizophrenia and schizotypal personality disorder |
| Q34367612 | Social appraisal in chronic psychosis: role of medial frontal and occipital networks |
| Q48451308 | Source-based morphometry of gray matter volume in men with first-episode schizophrenia. |
| Q37393231 | Spared and impaired aspects of motivated cognitive control in schizophrenia |
| Q33764345 | Spatial frequency discrimination in schizophrenia |
| Q48144270 | Spatial working memory deficits and clinical symptoms in schizophrenia: a 4-month follow-up study |
| Q30478989 | Steady state responses: electrophysiological assessment of sensory function in schizophrenia |
| Q36103322 | Stereologic analysis of the lateral geniculate nucleus of the thalamus in normal and schizophrenic subjects |
| Q36427986 | Stereological assessment of the dorsal anterior cingulate cortex in schizophrenia: absence of changes in neuronal and glial densities |
| Q48891013 | Stereological studies of capillary length density in the frontal cortex of schizophrenics |
| Q73553161 | Stereological studies of the schizophrenic brain |
| Q34098139 | Stress impairs prefrontal cortical function in rats and monkeys: role of dopamine D1 and norepinephrine alpha-1 receptor mechanisms |
| Q34567174 | Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments |
| Q35203213 | Subnucleus-specific loss of neurons in medial thalamus of schizophrenics |
| Q37325692 | Symptomatic and functional correlates of regional brain physiology during working memory processing in patients with recent onset schizophrenia |
| Q48172717 | Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness |
| Q48884472 | Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia |
| Q36339516 | Synchronous Changes of Cortical Thickness and Corresponding White Matter Microstructure During Brain Development Accessed by Diffusion MRI Tractography from Parcellated Cortex |
| Q60494632 | Synchronous Gamma activity: a review and contribution to an integrative neuroscience model of schizophrenia |
| Q60037831 | Synchronous dynamics for cognitive coordination: But how? |
| Q28076907 | Targeting Prefrontal Cortical Systems for Drug Development: Potential Therapies for Cognitive Disorders |
| Q34317550 | Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction |
| Q48962151 | Ten year progressive ventricular enlargement in schizophrenia: an MRI morphometrical study |
| Q33510901 | Thalamic transcriptome screening in three psychiatric states |
| Q28597453 | The Structural and Functional Organization of Cognition |
| Q34156147 | The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia |
| Q41609938 | The cortical dopamine system: role in memory and cognition |
| Q33951370 | The course of brain abnormalities in schizophrenia: can we slow the progression? |
| Q43923756 | The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. |
| Q43744085 | The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects |
| Q30882382 | The distribution and morphology of prefrontal cortex pyramidal neurons identified using anti-neurofilament antibodies SMI32, N200 and FNP7. Normative data and a comparison in subjects with schizophrenia, bipolar disorder or major depression. |
| Q33904974 | The emergence of modern neuroscience: some implications for neurology and psychiatry |
| Q73484909 | The growth-associated protein GAP-43 is increased in the hippocampus and in the gyrus cinguli in schizophrenia |
| Q33979202 | The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications |
| Q40903827 | The human striatum in schizophrenia. I. Increase in overall relative striatal volume in schizophrenics |
| Q42436896 | The human striatum in schizophrenia. II. Increased number of striatal neurons in schizophrenics |
| Q38582714 | The lifetime trajectory of schizophrenia and the concept of neurodevelopment |
| Q41743479 | The neuroanatomy and neurochemistry of schizophrenia |
| Q41880359 | The neurobiology of thought: the groundbreaking discoveries of Patricia Goldman-Rakic 1937-2003. |
| Q33725853 | The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia |
| Q37606626 | The psychoses: cluster 3 of the proposed meta-structure for DSM-V and ICD-11. |
| Q48303124 | The reduced neuropil hypothesis: a circuit based model of schizophrenia |
| Q48247779 | The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia. |
| Q96773916 | The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia |
| Q41693925 | The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders |
| Q41581743 | The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia |
| Q31161674 | The thalamus and schizophrenia: current status of research |
| Q33281339 | Tracking Alzheimer's disease |
| Q30543926 | Transcriptomics of cortical gray matter thickness decline during normal aging |
| Q48607692 | Two-dimensional versus three-dimensional cell counting |
| Q35135220 | Unchanged packing density but altered size of neurofilament immunoreactive neurons in the prefrontal cortex in schizophrenia and major depression. |
| Q24648426 | Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study |
| Q24541308 | Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients |
| Q42968242 | Update on the neurobiology of schizophrenia: a role for extracellular microdomains. |
| Q73155297 | Using a speech perception neural network simulation to explore normal neurodevelopment and hallucinated 'voices' in schizophrenia |
| Q38954274 | Visual Perception Disturbances in Schizophrenia: A Unified Model |
| Q37633507 | Visual Population Receptive Fields in People with Schizophrenia Have Reduced Inhibitory Surrounds. |
| Q48455176 | Visual object working memory function and clinical symptoms in schizophrenia |
| Q33754408 | Visual perception and working memory in schizotypal personality disorder. |
| Q35989231 | Visual white matter integrity in schizophrenia. |
| Q48547404 | Vitamin D, parathyroid hormone, serum calcium and phosphorus in patients with schizophrenia and major depression |
| Q30610218 | What happens in the brain of schizophrenia patients?: an investigation from the viewpoint of neuropathology |
| Q37696307 | What is schizophrenia: A neurodevelopmental or neurodegenerative disorder or a combination of both? A critical analysis |
| Q37735280 | When cortical development goes wrong: schizophrenia as a neurodevelopmental disease of microcircuits |
| Q37778420 | White matter neuron alterations in schizophrenia and related disorders |
| Q30491002 | Why do many psychiatric disorders emerge during adolescence? |
| Q59782767 | Why do schizophrenic patients hallucinate? |
| Q26999303 | Windows to the soul: vision science as a tool for studying biological mechanisms of information processing deficits in schizophrenia |
| Q43833363 | Working memory deficits in schizophrenia are not necessarily specific or associated with MRI-based estimates of area 46 volumes. |
| Q30454210 | Workshop on schizophrenia |
| Q87117734 | [Can long-term treatment with antipsychotic drugs lead to structural brain damage? Pro] |
| Q81160867 | [Current issues on schizoaffective disorder] |
| Q87945859 | [Frontal brain volume reduction due to antipsychotic drugs?] |
| Q37632867 | mGluR2/3 mechanisms in primate dorsolateral prefrontal cortex: evidence for both presynaptic and postsynaptic actions. |
Search more.